Reinsurance Group Of America (RGA) Gains Momentum As Fair Value Stays In Focus
Reinsurance Group of America (RGA) is in focus after recent share price moves, with the stock last closing at $238.06. Investors are assessing how this valuation compares with the company’s current fundamentals.
See our latest analysis for Reinsurance Group of America.
Recent trading has been supportive for Reinsurance Group of America, with a 30 day share price return of 11.95% and a year to date share price return of 17.02%. Over a longer horizon, total shareholder return of 26.01% over 1 year and 119.00% over 5 years indicates momentum that has been sustained rather than purely short term.
If you are comparing Reinsurance Group of America with other opportunities in the market, it can also be useful to scan 19 top founder-led companies
After that kind of run, Reinsurance Group of America is no longer an obvious bargain. The key issue now is whether the current price still compensates you for the risks you are taking.
Most Popular Narrative: 5.6% Undervalued
On the latest numbers, the most followed narrative puts Reinsurance Group of America’s fair value at $252.22 compared with the $238.06 last close, which frames the current upside case.
The company's leadership in digital underwriting solutions and customized reinsurance products, bolstered by data analytics and exclusive arrangements, enhances efficiency and pricing power, which is likely to improve net margins and generate higher earnings as these tech-enabled capabilities scale.
Curious what sits behind that $252.22 figure? The narrative refers to steady revenue expansion, firmer margins and a future earnings multiple that shifts from today’s starting point. The mix of growth, profitability and discount rate assumptions is all laid out for you.
Result: Fair Value of $252.22 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you also need to weigh risks such as earnings volatility in U.S. life and healthcare excess lines, as well as the impact of rising medical costs on Reinsurance Group of America’s margins.
Find out about the key risks to this Reinsurance Group of America narrative.
Another View on Reinsurance Group of America’s Valuation
The earlier fair value of $252.22 comes from analyst earnings and pricing assumptions. A different picture emerges when you look at Reinsurance Group of America on a simple P/E basis. The stock trades at 12.7x, compared with 6.3x for peers and 12.4x for the wider US Insurance sector.
The fair ratio for Reinsurance Group of America is 13.9x, which is higher than today’s P/E. That suggests some room for the market to move closer to that fair ratio over time, but also highlights that any setback in earnings expectations could be punished quickly when investors are already paying a richer multiple than peers. Which way do you think that balance tilts right now?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of optimism and concern around Reinsurance Group of America feels familiar, use the full data set now to benchmark the company against your own expectations and reach an informed view by weighing 4 key rewards and 1 important warning sign
Looking for more investment ideas beyond Reinsurance Group of America?
If Reinsurance Group of America has sharpened your focus, do not stop here. Broaden your watchlist with fresh ideas that match your own risk and return preferences.
- Target potential mispricings by scanning 56 high quality undervalued stocks that combine quality fundamentals with prices that may not fully reflect them.
- Strengthen your income focus by reviewing 8 dividend fortresses that pair higher yields with an emphasis on stability.
- Prioritise resilience by assessing 89 resilient stocks with low risk scores that score well on financial strength and risk controls.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com